Published on 17 Jan 2017

The first in the series features Prof Toby Maher talking about recently-published research into idiopathic pulmonary fibrosis (IPF), a condition where there is progressive scarring of the lungs. This limits the amount of oxygen that gets into a patient’s blood, causing breathlessness from everyday activities like walking

Published on 19 Jan 2015

Prof Maher has been an F1000 Faculty Member in the Respiratory Diseases Faculty since 2011. He is a clinician-scientist at the Royal Brompton hospital London and an academic at both University College London and Imperial College London, and in this video, he tells us about his research on idiopathic pulmonary fibrosis and interstitial and rare lung diseases.

Published on 11 Oct 2015

I talk to Prof Toby Maher from the British Lung Foundation about a little known lung disease called IPF and how it is claiming the lives of around 5,000 people in the UK every year.

Published on 18 May 2015

Prof Toby Maher, Royal Brompton Hospital, UK, talks about the impact of idiopathic pulmonary fibrosis (IPF) and the need to shed light on this 'invisible disease'

Published on 18 Sep 2013

Idiopathic pulmonary fibrosis (IPF) is a rare and deadly respiratory condition that most patients have never heard of until they're diagnosed. Learn how IPF progresses and about key symptoms such as the Velcro-like crackles heard in the lungs of 80% of IPF patients. This film features interviews from leading experts in IPF, Professor Vincent Cottin, Prof Toby Maher and Dr Luca Richeldi.

Published on 3 Sep 2014

Prof Toby Maher talks about initial discussions to have with patients when they are first diagnosed with idiopathic pulmonary fibrosis (IPF).

Published on 16 Oct 2015

Royal Brompton Hospital’s interstitial lung disease unit played a central part in the reclassification of idiopathic pulmonary fibrosis (IPF) and related idiopathic interstitial pneumonias in 2001.